However, we did not observe a significant relationship between ABCG2 expression and acquired chemoresistance, which is in agreement with another study that did not observe any difference in ABCG2 expression in A2780 ovarian cancer cell treated with cisplatin[79]. This evidence concerns the gene ABCG2 and ovarian carcinoma.